Sino Biopharmaceutical Ltd banner

Sino Biopharmaceutical Ltd
HKEX:1177

Watchlist Manager
Sino Biopharmaceutical Ltd Logo
Sino Biopharmaceutical Ltd
HKEX:1177
Watchlist
Price: 6.42 HKD -0.16% Market Closed
Market Cap: HK$120.4B

Relative Value

The Relative Value of one Sino Biopharmaceutical Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 6.42 HKD, Sino Biopharmaceutical Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Sino Biopharmaceutical Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Sino Biopharmaceutical Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
Sino Biopharmaceutical Ltd
HKEX:1177
114.9B HKD 3.3 26.4 14.7 14.7
US
Eli Lilly and Co
NYSE:LLY
995.7B USD 15.2 48.1 32.4 34.5
US
Johnson & Johnson
NYSE:JNJ
573.2B USD 6.1 21.4 14.9 18.3
CH
Roche Holding AG
SIX:ROG
281.7B CHF 4.6 30 12.7 14.8
US
Merck & Co Inc
NYSE:MRK
300.5B USD 4.7 16.6 10.4 12.1
CH
Novartis AG
SIX:NOVN
231.3B CHF 5.3 21.2 13.1 16.8
UK
AstraZeneca PLC
LSE:AZN
217.3B GBP 5.2 32.1 15.3 22.4
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.7 9.3 11
US
Pfizer Inc
NYSE:PFE
153B USD 2.5 19.8 7.4 9.9
US
Bristol-Myers Squibb Co
NYSE:BMY
125.7B USD 2.6 20.8 7.3 9.5
P/E Multiple
Earnings Growth PEG
HK
Sino Biopharmaceutical Ltd
HKEX:1177
Average P/E: 24.9
26.4
18%
1.5
US
Eli Lilly and Co
NYSE:LLY
48.1
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
21.4
6%
3.6
CH
Roche Holding AG
SIX:ROG
30
29%
1
US
Merck & Co Inc
NYSE:MRK
16.6
14%
1.2
CH
Novartis AG
SIX:NOVN
21.2
15%
1.4
UK
AstraZeneca PLC
LSE:AZN
32.1
38%
0.8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
12.7
7%
1.8
US
Pfizer Inc
NYSE:PFE
19.8
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
20.8
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
HK
Sino Biopharmaceutical Ltd
HKEX:1177
Average EV/EBITDA: 42.8
14.7
13%
1.1
US
Eli Lilly and Co
NYSE:LLY
32.4
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
14.9
2%
7.5
CH
Roche Holding AG
SIX:ROG
12.7
5%
2.5
US
Merck & Co Inc
NYSE:MRK
10.4
7%
1.5
CH
Novartis AG
SIX:NOVN
13.1
9%
1.5
UK
AstraZeneca PLC
LSE:AZN
15.3
10%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
7%
1.3
US
Pfizer Inc
NYSE:PFE
7.4
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.3
-9%
N/A